Results From Covid Vaccine Trials. Continuing the spate of stunning news about COVID-19 vaccines the biotech company Moderna announced the final results of the 30000-person efficacy trial for its candidate in a press release. Final results from the trials of Modernas vaccine against Covid-19 confirm it has 94 efficacy and nobody who was vaccinated with it developed severe disease says the company kickstarting the.
Phase 3 Results In Sight For Some While One Vaccine Is Put On Hold Covid 19 Vaccine Race Month 9 Absolutely Maybe from absolutelymaybe.plos.org
Continuing the spate of stunning news about COVID-19 vaccines the biotech company Moderna announced the final results of the 30000-person efficacy trial for its candidate in a press release. There were 10 severe cases of COVID-19 observed in the trial with nine of the cases occurring in the placebo group and one in the BNT162b2 vaccinated group. 9 Rather than studying severe disease these mega-trials all set a primary endpoint of symptomatic covid-19 of essentially any severity.
There were 10 severe cases of COVID-19 observed in the trial with nine of the cases occurring in the placebo group and one in the BNT162b2 vaccinated group.
The first full peer-reviewed results of phase 3 trials of the COVID-19 vaccine developed by AstraZeneca and Oxford University show that it is safe and up to 90 effective in preventing infection supporting regulatory submissions for emergency use. The vaccine also demonstrated efficacy in preventing severe COVID-19. If trial data for covid-19 candidate vaccines are prematurely announced this may threaten the integrity and credibility of the trials. A laboratory positive result plus mild symptoms such as cough and fever count as outcome events table 1.
